foxo4 dri peptide senolytic 2024 foxo4-dri human trial Class II senolytics inhibit survival pathways elicited by senescent bpc 157 intramuscular GLOW Further Options:Signature Double Pack MBC
Pay in 4 interest-free payments of $6.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2